Mayne Pharma Group Limited (ASX:MYX)

Mayne Pharma Group Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 1, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Market Capitalization	262	227	406	383	367	441
Market Cap Growth	-37.52%	-44.20%	6.16%	4.25%	-16.81%	-21.88%
Enterprise Value	226	202	321	264	273	717
Last Close Price	3.23	2.79	5.00	4.71	4.40	4.40

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 1, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
PE Ratio	11.92	9.26	-	-	3.13	-
Forward PE	-	150.33	150.33	150.33	150.33	150.33
PS Ratio	0.68	0.59	1.00	0.99	2.00	2.81
PB Ratio	0.67	0.58	1.10	0.84	0.58	0.82
P/TBV Ratio	-	-	-	-	19.18	3.46
P/FCF Ratio	24.02	20.75	78.23	-	-	-
P/OCF Ratio	18.92	16.35	23.25	-	-	-
PEG Ratio	-	0.51	0.51	0.51	0.51	0.51

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 1, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
EV/Sales Ratio	0.59	0.53	0.79	0.68	1.49	4.56
EV/EBITDA Ratio	6.24	6.09	7.63	-	-	-
EV/FCF Ratio	20.66	18.47	61.85	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 1, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Debt / Equity Ratio	0.11	0.11	0.11	0.09	0.08	0.77
Debt / EBITDA Ratio	1.19	1.19	0.90	-	-	-
Debt / FCF Ratio	3.96	3.96	7.95	-	-	-
Net Debt / Equity Ratio	-0.09	-0.09	-0.16	-0.24	-0.27	0.59
Net Debt / EBITDA Ratio	-1.11	-1.11	-1.40	7.62	1.48	-6.81
Net Debt / FCF Ratio	-3.37	-3.37	-11.39	4.75	3.38	-18.34
Asset Turnover	0.40	0.40	0.38	0.33	0.14	0.11
Inventory Turnover	2.56	2.56	2.57	2.16	1.05	0.81
Quick Ratio	0.98	0.98	1.08	1.03	1.38	0.61
Current Ratio	1.31	1.31	1.35	1.33	1.78	0.81
Return on Equity (ROE)	8.20%	8.20%	-21.85%	-30.98%	-54.14%	-33.61%
Return on Assets (ROA)	-1.73%	-1.73%	-1.28%	-4.07%	-9.04%	-5.57%
Return on Invested Capital (ROIC)	-6.55%	-6.97%	-6.73%	-19.33%	-27.89%	-13.07%
Return on Capital Employed (ROCE)	-4.10%	-4.10%	-2.90%	-9.80%	-19.60%	-18.60%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 1, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Earnings Yield	9.33%	10.80%	-23.10%	-45.53%	31.94%	-63.75%
FCF Yield	4.16%	4.82%	1.28%	-6.08%	-13.91%	-3.90%
Payout Ratio	-	-	-	-	38.63%	-
Buyback Yield / Dilution	-34.30%	-34.30%	0.60%	3.11%	0.15%	-4.74%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 1, 2026

Data Sources Report a data error